Application of heterologous extracellular vesicles and their analogs in anti-tumor activity research
Related Experiment Video
Updated: Sep 19, 2025
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Jianguo Gao1, Yanqing Wu1, Yuwei Zhao1
1School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, PR China.
Abstract:
Extracellular vesicles and their analogues can mediate intercellular communication for gene regulation, thereby activating corresponding cellular functions, which demonstrates promising applications in disease diagnosis and treatment. Extensive studies have indicated that extracellular vesicles and their analogues exhibit remarkable efficacy in various pharmacological activities, including anti-tumor effects, immune modulation, prevention and treatment of cardiovascular diseases, as well as tissue regeneration. Heterologous extracellular vesicles and their analogues possess diverse biological activities attributed to their compositions, distributions, and mechanisms of action. Their specific targeting ability, high biocompatibility, and low immunogenicity render them ideal delivery vehicles for precision therapeutic interventions. This article aims to comprehensively review the mechanisms of action of extracellular vesicles and their analogues in anti-tumor activity, as well as their unique advantages as drug delivery carriers, with the goal of providing a necessary reference foundation for further application and development in anti-tumor therapy.
Insights
Extracellular vesicles and their analogues are key for intercellular communication and show promise in disease treatment. Their unique properties make them ideal drug delivery vehicles for precision therapies, especially in anti-tumor applications.
Area of Science:
- Biomedical Sciences
- Cell Biology
- Nanotechnology
Background:
- Extracellular vesicles (EVs) and their analogues mediate intercellular communication, influencing gene regulation and cellular functions.
- EVs demonstrate significant therapeutic potential in anti-tumor effects, immune modulation, cardiovascular disease, and tissue regeneration.
- Their composition and mechanism of action dictate diverse biological activities.
Purpose of the Study:
- To comprehensively review the mechanisms of action of EVs and their analogues in anti-tumor activity.
- To highlight the advantages of EVs as drug delivery carriers for precision therapeutics.
- To provide a foundational reference for advancing EV-based anti-tumor therapies.
Main Methods:
- Literature review of studies on extracellular vesicles and their analogues.
- Analysis of mechanisms underlying EV-mediated gene regulation and cellular functions.
- Evaluation of EV properties, including targeting ability, biocompatibility, and immunogenicity.
Main Results:
- EVs and their analogues exhibit potent anti-tumor effects and modulate immune responses.
- Their specific targeting, biocompatibility, and low immunogenicity make them effective drug delivery systems.
- Diverse biological activities are linked to the specific compositions and actions of EVs.
Conclusions:
- Extracellular vesicles and their analogues are versatile tools for intercellular communication and therapeutic interventions.
- Their application as drug delivery vehicles offers significant advantages for precision medicine, particularly in oncology.
- Further research into EVs will facilitate their broader clinical application in disease treatment.
